Research Article
Integrated Analyses of the Expression and Prognostic Value of EPHB6 in Cervical Cancer and Its Correlation with Immune Infiltrates
Table 3
Univariate and multivariate analyses on disease-specific survivals based on the cox regression model.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Age | 302 | | | | | ≤50 | 186 | Reference | | | | >50 | 116 | 1.295 (0.761–2.204) | 0.340 | | | Clinical stage | 295 | | | | | Stage I and Stage II | 227 | Reference | | | | Stage III and Stage IV | 68 | 2.675 (1.550–4.615) | <0.001 | 2.800 (1.620–4.839) | <0.001 | Histologic grade | 271 | | | | | G1 and G2 | 152 | Reference | | | | G3 and G4 | 119 | 0.922 (0.514–1.654) | 0.785 | | | EPHB6 | 302 | | | | | Low | 149 | Reference | | | | High | 153 | 0.473 (0.275–0.813) | 0.007 | 0.454 (0.263–0.783) | 0.005 |
|
|
The bold values mean statistically significant.
|